Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 8-K Event Other events
  4. 8-K Event Material agreement · Acquisition or sale completed
  5. 4 Shares withheld for taxes Chief Financial Officer gave up 346 shares (to pay taxes)
  6. 8-K Event Executive or director change
  7. 4 Grant or award Director acquired 2,285 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 4,000 shares at $59.38 ($237,529)
  10. 8-K Event Other events
  11. 4 Shares withheld for taxes CHIEF LEGAL OFFICER & gave up 897 shares (to pay taxes)
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 4 Other acquisition PRESIDENT & CHIEF OPERATING acquired 376 shares (other)
  15. 4 Other acquisition Chief Financial Officer acquired 375 shares (other)
  16. 4 Grant or award Director acquired 1,142 shares (grant or award)
  17. 4 Grant or award Director acquired 1,142 shares (grant or award)
  18. 4 Grant or award Director acquired 1,142 shares (grant or award)
  19. 4 Grant or award Director acquired 1,142 shares (grant or award)
  20. 4 Grant or award Director acquired 1,142 shares (grant or award)

Page 16 of 115 · 2,300 filings